Download PDFPDF

Communication
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address